Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 804-805

  Reitz, André ^a   Schurch, Brigitte ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Bladder, neurogenic; Botulinum toxins; Drug resistance

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; CROSS REACTING ANTIBODY; NEUROTOXIN;

ADULT; ARTICLE; CASE REPORT; DETRUSOR MUSCLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PARAPLEGIA; PRIORITY JOURNAL; SIDE EFFECT; URINE INCONTINENCE; URODYNAMICS; ANTIBODY PRODUCTION; DRUG APPROVAL; DRUG PROTEIN BINDING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; NOTE; TREATMENT INDICATION; URINARY TRACT DISEASE;

EID: 0347759834     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000108407.53880.6a     Document Type: Article

References (3)

1. Schurch, B., Stöhrer, M., Kramer, G., Schmid, D. M., Gaul, G. and Hauri, D.: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol, 164: 692, 2000
2. Gordon, P. H., Gooch, C. L. and Green, P. E.: Extensor digitorum brevis test and resistance to botulinum toxin type A. Muscle Nerve, 26: 828, 2002
3. Aoki, K. R.: Pharmacology and immunology of botulinum toxin serotypes. J Neurol, suppl., 248: 3, 2001